For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Placebo | Participants received placebo in the study. | 0 | None | 0 | 13 | 6 | 13 | View |
| Temanogrel 120 mg | Participants received temanogrel 120 mg in the study. | 0 | None | 0 | 13 | 4 | 13 | View |
| Temanogrel 60 mg | Participants received temanogrel 60 mg in this study. | 0 | None | 0 | 13 | 3 | 13 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hypoaesthesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Medra v24.0 | View |
| Head discomfort | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Medra v24.0 | View |
| Oedema peripheral | NON_SYSTEMATIC_ASSESSMENT | General disorders | Medra v24.0 | View |
| Peripheral swelling | NON_SYSTEMATIC_ASSESSMENT | General disorders | Medra v24.0 | View |
| Dizziness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Medra v24.0 | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Medra v24.0 | View |
| Blood creatine phosphokinase increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | Medra v24.0 | View |
| Urinary tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Medra v24.0 | View |
| Hypercholesterolaemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | Medra v24.0 | View |
| Arthralgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | Medra v24.0 | View |